ATHE: Alterity Therapeutics Company Short-Term Debt
The absence of direct market competitors and patent protection for software treating rare pathologies make the asset dynamics of Alterity Therapeutics (ATHE) unique. The company's short-term debts illustrate the current balance of liabilities, where the value of 0.00 shows the actual magnitude of the burden. This is supported by large-scale investments in the fight against Alzheimer's and Parkinson's, as well as the development of methods to block neuron degeneration to slow cellular aging.
Alterity Therapeutics Ltd. (ATHE) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Alterity Therapeutics|ATHE - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Alterity Therapeutics Ltd|ATHE - Company Cumulative Debt|Debt to Book Capitalization Ratio Alterity Therapeutics Limited|ATHE - Company Long-Term Loans and Borrowings|Company Short-Term Debts Alterity Therapeutics|Quick Liquidity Indicator alteritytherapeutics.com
- net income and valuation multiples indicators:
Basic company analysis:ATHE - alteritytherapeutics.com
This indicator aggregates total credit obligations with maturities of up to one year, allowing for an assessment of liquidity and default risk within the immediate cycle. An analysis of short-term debt reveals the budget's sensitivity to cash flow gaps, which is critical for Alterity Therapeutics (ATHE), as clinical development costs are rising in the complete absence of commercial revenue.
Competing companies
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debt SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc - Company Current Liabilities|Amount of Current Liabilities DNLI (Denali Corp)|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt biohavenpharma.com|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Trevi Therapeutics Inc - Company Short-Term Loans and Borrowings|PRAX (Praxis Medicines) - Company Short-Term Debts|Anavex Life Sciences Corp (AVXL) - Short-Term Debt Volume|Company Current Liabilities CBLL (CeriBell, Inc.)|Amount of Current Liabilities PRTA|Alector - Company Current Liabilities|Annexon Biosciences (ANNX) - Short-Term Debt|OMER: Company Current Liabilities|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|ACIU (AC Immune) - Company Current Liabilities|VYGR: Amount of Current Liabilities|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|SCLX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TVGN|ACOG - Short-Term Debt|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|ASRT - Company Short-Term Debts|coyatherapeutics.com (COYA) - Company Short-Term Debt|Current Liabilities VTGN (Vistagen)|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Short-Term Debt acumenpharm.com ABOS|Company Current Liabilities CRVO (CervoMed)|Company Short-Term Debts clene.com (CLNN)|PepGen - Company Current Liabilities|Amount of Current Liabilities JUNS (jupiterneurosciences.com)|Relmada Therapeutics - Company Short-Term Debts|Short-Term Debt Volume annovisbio.com ANVS|GRCE: Company Short-Term Debts|Company Current Liabilities Firefly Neuroscience, Inc.|Company Short-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Short-Term Debts RVPH|Company Short-Term Debts metaviatx.com (MTVA)|NeurAxis - Company Current Liabilities|Amount of Current Liabilities HSDT (Helius Medical Technologies, Inc.)|Passage Bio Corp - Company Short-Term Debts|Company Short-Term Loans and Borrowings NEUP (Neuphoria Therapeutics Inc.)|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debts CYCN|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Intra-Cellular|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Company Short-Term Debt MRNS (Marinus Pharmaceuticals Inc)|NKGen - Company Current Liabilities|Amount of Current Liabilities NRBO (NeuroBo Pharma)|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt synaptogen.com|Trevena (TRVN) - Company Short-Term Debt|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Cerevel Corp (CERE) - Short-Term Debt Volume